ASHLEY CHISM: Open Payments
NPI 1255181095 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,222 in 96 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,085 · 2025 $2,222
Food & beverage: $2,210Education: $12
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 18 | $477 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $316 |
| Otsuka America Pharmaceutical, Inc. | 9 | $252 |
| Janssen Pharmaceuticals, Inc | 16 | $248 |
| Teva Pharmaceuticals USA, Inc. | 8 | $208 |
| Vanda Pharmaceuticals Inc. | 7 | $190 |
| Axsome Therapeutics, Inc. | 8 | $161 |
| ABBVIE INC. | 11 | $154 |
| Alkermes, Inc. | 4 | $77 |
| Lundbeck LLC | 4 | $76 |
Products named: COBENFY, CAPLYTA, INVEGA SUSTENNA, FANAPT, UZEDY, Auvelity, VRAYLAR, REXULTI.
Industry payments across MS — which companies pay providers there.
